These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 18365910)

  • 1. Effect of guanylin peptides on pancreas steatosis and function in experimental diet-induced obesity and after bariatric surgery.
    Otero A; Becerril S; Martín M; Cienfuegos JA; Valentí V; Moncada R; Catalán V; Gómez-Ambrosi J; Burrell MA; Frühbeck G; Rodríguez A
    Front Endocrinol (Lausanne); 2023; 14():1185456. PubMed ID: 37274331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities.
    Prasad H; Mathew JKK; Visweswariah SS
    Front Endocrinol (Lausanne); 2022; 13():911459. PubMed ID: 35846281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potential.
    Entezari AA; Snook AE; Waldman SA
    Expert Opin Ther Targets; 2021 May; 25(5):335-346. PubMed ID: 34056991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanylin, Uroguanylin and Guanylate Cyclase-C Are Expressed in the Gastrointestinal Tract of Horses.
    Cappelli K; Gialletti R; Tesei B; Bassotti G; Fettucciari K; Capomaccio S; Bonfili L; Cuccioloni M; Eleuteri AM; Spaterna A; Laus F
    Front Physiol; 2019; 10():1237. PubMed ID: 31611814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients.
    Snook AE; Baybutt TR; Xiang B; Abraham TS; Flickinger JC; Hyslop T; Zhan T; Kraft WK; Sato T; Waldman SA
    J Immunother Cancer; 2019 Apr; 7(1):104. PubMed ID: 31010434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models.
    Schreiber AR; Nguyen A; Bagby SM; Arcaroli JJ; Yacob BW; Quackenbush K; Guy JL; Crowell T; Stringer B; Danaee H; Kalebic T; Messersmith WA; Pitts TM
    Clin Cancer Drugs; 2018; 5(1):42-49. PubMed ID: 30631747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo.
    Gallery M; Zhang J; Bradley DP; Brauer P; Cvet D; Estevam J; Danaee H; Greenfield E; Li P; Manfredi M; Loke HK; Rabino C; Stringer B; Williamson M; Wyant T; Yang J; Zhu Q; Abu-Yousif A; Veiby OP
    PLoS One; 2018; 13(1):e0191046. PubMed ID: 29370189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistent expression of guanylyl cyclase-C in primary and metastatic gastrointestinal cancers.
    Danaee H; Kalebic T; Wyant T; Fassan M; Mescoli C; Gao F; Trepicchio WL; Rugge M
    PLoS One; 2017; 12(12):e0189953. PubMed ID: 29261789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Heat-Stable Enterotoxin Receptor, Guanylyl Cyclase C, as a Pharmacological Target in Colorectal Cancer Immunotherapy: A Bench-to-Bedside Current Report.
    Baybutt TR; Aka AA; Snook AE
    Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28914772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C.
    Almhanna K; Wright D; Mercade TM; Van Laethem JL; Gracian AC; Guillen-Ponce C; Faris J; Lopez CM; Hubner RA; Bendell J; Bols A; Feliu J; Starling N; Enzinger P; Mahalingham D; Messersmith W; Yang H; Fasanmade A; Danaee H; Kalebic T
    Invest New Drugs; 2017 Oct; 35(5):634-641. PubMed ID: 28527133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study.
    Bang YJ; Takano T; Lin CC; Fasanmade A; Yang H; Danaee H; Asato T; Kalebic T; Wang H; Doi T
    Cancer Res Treat; 2018 Apr; 50(2):398-404. PubMed ID: 28494535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pendrin, a novel transcriptional target of the uroguanylin system.
    Rozenfeld J; Tal O; Kladnitsky O; Adler L; Efrati E; Carrithers SL; Alper SL; Zelikovic I
    Cell Physiol Biochem; 2013; 32(7):221-37. PubMed ID: 24429828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defying the stereotype: non-canonical roles of the Peptide hormones guanylin and uroguanylin.
    Basu N; Visweswariah SS
    Front Endocrinol (Lausanne); 2011; 2():14. PubMed ID: 22654795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uroguanylin inhibits proliferation of pancreatic cancer cells.
    Kloeters O; Friess H; Giese N; Buechler MW; Cetin Y; Kulaksiz H
    Scand J Gastroenterol; 2008; 43(4):447-55. PubMed ID: 18365910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
    Shailubhai K; Yu HH; Karunanandaa K; Wang JY; Eber SL; Wang Y; Joo NS; Kim HD; Miedema BW; Abbas SZ; Boddupalli SS; Currie MG; Forte LR
    Cancer Res; 2000 Sep; 60(18):5151-7. PubMed ID: 11016642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis.
    Guweidhi A; Kleeff J; Giese N; El Fitori J; Ketterer K; Giese T; Büchler MW; Korc M; Friess H
    Carcinogenesis; 2004 Sep; 25(9):1575-85. PubMed ID: 15073049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of atrial natriuretic peptide, urodilatin, guanylin and uroguanylin in the isolated perfused rat kidney.
    Santos-Neto MS; Carvalho AF; Monteiro HS; Forte LR; Fonteles MC
    Regul Pept; 2006 Sep; 136(1-3):14-22. PubMed ID: 16814407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics.
    Forte LR
    Pharmacol Ther; 2004 Nov; 104(2):137-62. PubMed ID: 15518884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intestinal guanylin system and seawater adaptation in eels.
    Takei Y; Yuge S
    Gen Comp Endocrinol; 2007; 152(2-3):339-51. PubMed ID: 17561018
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.